241 related articles for article (PubMed ID: 33400406)
1. Ingenol Mebutate and the Treatment of Actinic Keratosis.
Heron CE; Feldman SR
J Drugs Dermatol; 2021 Jan; 20(1):102-104. PubMed ID: 33400406
[TBL] [Abstract][Full Text] [Related]
2. Randomized Trial of Four Treatment Approaches for Actinic Keratosis.
Jansen MHE; Kessels JPHM; Nelemans PJ; Kouloubis N; Arits AHMM; van Pelt HPA; Quaedvlieg PJF; Essers BAB; Steijlen PM; Kelleners-Smeets NWJ; Mosterd K
N Engl J Med; 2019 Mar; 380(10):935-946. PubMed ID: 30855743
[TBL] [Abstract][Full Text] [Related]
3. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
Berman B; Nestor MS; Newburger J; Park H; Swenson N
J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial.
Miola AC; Ferreira ER; Lima TRR; Schmitt JV; Abbade LPF; Miot HA
Br J Dermatol; 2018 Nov; 179(5):1081-1087. PubMed ID: 29862491
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial.
Togsverd-Bo K; Halldin C; Sandberg C; Gonzalez H; Wennberg AM; Sørensen SS; Wulf HC; Haedersdal M
Br J Dermatol; 2018 Apr; 178(4):903-909. PubMed ID: 28796885
[TBL] [Abstract][Full Text] [Related]
6. Ingenol Mebutate vs. Daylight Photodynamic Therapy in a Kidney Transplant Recipient.
Mühlstädt M
Dermatology; 2016; 232 Suppl 1():20-3. PubMed ID: 27513345
[TBL] [Abstract][Full Text] [Related]
7. Effect of Field Treatment of Actinic Keratosis With Ingenol Mebutate Gel on the Identification of Lesions for Biopsy.
Bettencourt MS
J Drugs Dermatol; 2015 Aug; 14(8):813-8. PubMed ID: 26267725
[TBL] [Abstract][Full Text] [Related]
8. Exploring the use of ingenol mebutate to prevent non-melanoma skin cancer.
Erlendsson AM
Dan Med J; 2017 Nov; 64(11):. PubMed ID: 29115209
[TBL] [Abstract][Full Text] [Related]
9. A randomized split-face clinical trial analyzing daylight photodynamic therapy with methyl aminolaevulinate vs ingenol mebutate gel for the treatment of multiple actinic keratoses of the face and the scalp.
Moggio E; Arisi M; Zane C; Calzavara-Pinton I; Calzavara-Pinton P
Photodiagnosis Photodyn Ther; 2016 Dec; 16():161-165. PubMed ID: 27530375
[TBL] [Abstract][Full Text] [Related]
10. A Randomized Split-Face Clinical Trial of Photodynamic Therapy with Methyl Aminolevulinate versus Ingenol Mebutate Gel for the Treatment of Multiple Actinic Keratoses of the Face and Scalp.
Zane C; Fabiano A; Arisi M; Calzavara-Pinton P
Dermatology; 2016; 232(4):472-7. PubMed ID: 27578305
[TBL] [Abstract][Full Text] [Related]
11. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
[TBL] [Abstract][Full Text] [Related]
12. Current therapies for actinic keratosis.
Dianzani C; Conforti C; Giuffrida R; Corneli P; di Meo N; Farinazzo E; Moret A; Magaton Rizzi G; Zalaudek I
Int J Dermatol; 2020 Jun; 59(6):677-684. PubMed ID: 32012240
[TBL] [Abstract][Full Text] [Related]
13. Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
Schmitt AR; Bordeaux JS
Clin Dermatol; 2013; 31(6):712-7. PubMed ID: 24160275
[TBL] [Abstract][Full Text] [Related]
14. PICATO (ingenol mebutate 0.015% and 0.05% gels): a novel treatment for actinic keratosis.
Abramovits W; Oquendo M; Vincent KD; Gupta AK
Skinmed; 2013; 11(2):111-5. PubMed ID: 23745230
[No Abstract] [Full Text] [Related]
15. Real-World Effectiveness and Safety of Field- and Lesion-Directed Treatments for Actinic Keratosis.
Hansen JB; Larsson T; Dunkelly-Allen N; Veverka KA; Feldman SR
J Drugs Dermatol; 2020 Aug; 19(8):756-762. PubMed ID: 32804451
[TBL] [Abstract][Full Text] [Related]
16. A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands.
Jansen MHE; Kessels JPHM; Merks I; Nelemans PJ; Kelleners-Smeets NWJ; Mosterd K; Essers BAB
Br J Dermatol; 2020 Oct; 183(4):738-744. PubMed ID: 31961446
[TBL] [Abstract][Full Text] [Related]
17. Ameluz for actinic keratoses.
Med Lett Drugs Ther; 2016 Dec; 58(1509):155-156. PubMed ID: 27906150
[No Abstract] [Full Text] [Related]
18. Local interventions for actinic keratosis in organ transplant recipients: a systematic review.
Heppt MV; Steeb T; Niesert AC; Zacher M; Leiter U; Garbe C; Berking C
Br J Dermatol; 2019 Jan; 180(1):43-50. PubMed ID: 30188570
[TBL] [Abstract][Full Text] [Related]
19. Current management of actinic keratoses.
Shoimer I; Rosen N; Muhn C
Skin Therapy Lett; 2010 May; 15(5):5-7. PubMed ID: 20505896
[TBL] [Abstract][Full Text] [Related]
20. Methyl-aminolevulinic acid photodynamic therapy for actinic keratoses: a useful treatment or a risk factor? A retrospective study.
Bardazzi F; Loi C; Magnano M; Burtica EC; Giordano F; Patrizi A
J Dermatolog Treat; 2015 Apr; 26(2):168-70. PubMed ID: 24724569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
